JPRN-jRCT2080222230未知3 期
A Phase III, Randomized, Double-blind, Active-controlled 12 week Study Evaluating the Efficacy and Safety of KRP-AB1102F DPI Compared with KRP-AB1102 DPI in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 40age old 至 ot applicable（—）
- 性别
- All
入选标准
- •COPD patients with post-bronchodilator FEV1 between 30 and 80 % of predicted
排除标准
- •- History or current diagnosis of asthma
- •-Patient hospitalized for an acute COPD exacerbation within 3 months prior to screening visit, and others.
研究者
相似试验
已完成
3 期
A clinical study to assess the efficacy and safety of Empagliflozin and Sitagliptin Tablets in diabetic patients.CTRI/2023/12/060549Exemed Pharmaceuticals312
尚未招募
3 期
A clinical study to assess the efficacy and safety of Dapagliflozin plus Telmisartan Tablets in kidney patients.CTRI/2024/01/061927Exemed Pharmaceuticals
已完成
3 期
A clinical study to assess the efficacy and safety of Sitagliptin and Empagliflozin Tablets in diabetic patients.CTRI/2023/12/060517Synokem Pharmaceuticals Ltd314
尚未招募
3 期
A study to assess the efficacy and safety of Empagliflozin, Sitagliptin and Metformin Tablets in diabetic patients.CTRI/2024/04/066077Exemed Pharmaceuticals
已完成
3 期
A study to assess the efficacy and safety of combination of Dextromethorphan and Bupropion Tablets in patients with depression.CTRI/2023/06/053474Exemed Pharmaceuticals212